Klacid IV 500mg Powder for Concentrate for Solution for Infusion Irland - engelsk - HPRA (Health Products Regulatory Authority)

klacid iv 500mg powder for concentrate for solution for infusion

mylan ire healthcare limited - clarithromycin - powder for concentrate for solution for infusion - 500 milligram(s) - macrolides; clarithromycin - antibacterial for systemic use, macrolide - it is indicated for treatment of infections caused by susceptible organisms in the following conditions: lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia. upper respiratory tract infections for example, sinusitis and pharyngitis. skin and soft tissue infections.

Clarithromycin 250mg film-coated Tablets Malta - engelsk - Medicines Authority

clarithromycin 250mg film-coated tablets

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - clarithromycin - film-coated tablet - clarithromycin 250 mg - antibacterials for systemic use

Clarithromycin 500mg film-coated Tablets Malta - engelsk - Medicines Authority

clarithromycin 500mg film-coated tablets

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - clarithromycin - film-coated tablet - clarithromycin 500 mg - antibacterials for systemic use

Klacid 250 mg film-coated tablets Irland - engelsk - HPRA (Health Products Regulatory Authority)

klacid 250 mg film-coated tablets

mylan ire healthcare limited - clarithromycin - film-coated tablet - 250 milligram(s) - macrolides; clarithromycin - antibacterial for systemic use, macrolide - it is indicated for the treatment of infections due to susceptible organisms. such infections include: 1. lower respiratory tract infections (e.g. bronchitis, pneumonia). 2. upper respiratory tract infections (e.g. pharyngitis, sinusitis). 3. skin and soft tissue infections (e.g. folliculitis, cellulitis, erysipelas). 4. disseminated or localised mycobacterial infections due to mycobacterium avium or mycobacterium intracellulare. localised infections due to mycobacterium chelonae, mycobacterium fortuitum or mycobacterium kansasii. 5. clarithromycin is indicated for the prevention of disseminated mycobacterium avium complex infection in hivinfected patients with cd4 lymphocyte counts less than or equal to 100/mm3. 6. clarithromycin in the presence of acid suppression is indicated for the eradication of h. pylori, resulting in decreased recurrence of duodenal ulcer. (see further information).

Klacid LA 500mg Modified release tablets Irland - engelsk - HPRA (Health Products Regulatory Authority)

klacid la 500mg modified release tablets

mylan ire healthcare limited - clarithromycin - modified-release tablet - 500 milligram(s) - macrolides; clarithromycin - antibacterial for systemic use, macrolide - it is indicated for treatment of infections caused by susceptible organisms. indications include:  lower respiratory tract infections for example bronchitis and pneumonia.  upper respiratory tract infections for example sinusitis and pharyngitis.  skin and soft tissue infections for example folliculitis, cellulitis and erysipelas.

Klacid Paediatric Suspension 125mg/5ml, Granules for Oral Suspension Irland - engelsk - HPRA (Health Products Regulatory Authority)

klacid paediatric suspension 125mg/5ml, granules for oral suspension

mylan ire healthcare limited - clarithromycin - granules for oral suspension - 125 mg/5ml - macrolides; clarithromycin - antibacterial for systemic use, macrolide - it is indicated for the treatment of infections caused by susceptible organisms. indications include o lower respiratory tract infections o upper respiratory tract infections o skin and skin structure infections o acute otitis media

Klacid 250mg/5ml Granules for Oral Suspension Irland - engelsk - HPRA (Health Products Regulatory Authority)

klacid 250mg/5ml granules for oral suspension

mylan ire healthcare limited - clarithromycin - granules for oral suspension - 250 mg/5ml - macrolides; clarithromycin - antibacterial for systemic use, macrolide - it is indicated for the treatment of infections caused by susceptible organisms. indications include: lower respiratory tract infections. upper respiratory tract infections. skin and skin structure infections. acute otitis media.

Clarithromycin Krka 250 mg film-coated tablets Irland - engelsk - HPRA (Health Products Regulatory Authority)

clarithromycin krka 250 mg film-coated tablets

krka, d.d., novo mesto - clarithromycin - film-coated tablet - 250 milligram(s) - macrolides; clarithromycin

Clarithromycin Krka 500 mg film-coated tablets Irland - engelsk - HPRA (Health Products Regulatory Authority)

clarithromycin krka 500 mg film-coated tablets

krka, d.d., novo mesto - clarithromycin - film-coated tablet - 500 milligram(s) - macrolides; clarithromycin

ERYTHROCIN I.V. POWDER FOR SOLUTION Canada - engelsk - Health Canada

erythrocin i.v. powder for solution

amdipharm limited - erythromycin (erythromycin lactobionate) - powder for solution - 500mg - erythromycin (erythromycin lactobionate) 500mg - erythromycins